JLABS @ LabCentral QuickFire Challenge

JLABS @ LabCentral QuickFire Challenge

Challenge ended

Residency at JLABS

Consumer Health
Digital Health
Medical Device

Winners

Image paragraph

Cyteir Therapeutics is developing new drugs to treat cancer and chronic autoimmunity.

Image paragraph

Riparian Pharmaceuticals is an early-stage biotechnology company employing innovative models of vascular pathophysiology to discover novel therapeutics.

Image paragraph

XTuit Pharmaceuticals is pursuing novel approaches to improving cancer therapy by targeting the tumor microenvironment.

The Challenge

In honor of the upcoming Grand Opening of JLABS @ LabCentral, Johnson & Johnson Innovation has launched a QuickFire Challenge to award new game-changing early-stage innovation companies with the use of a bench, workstation and access to the JLABS @ LabCentral community for one year.